1. Home
  2. THAR vs CNEY Comparison

THAR vs CNEY Comparison

Compare THAR & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • CNEY
  • Stock Information
  • Founded
  • THAR 2017
  • CNEY 2018
  • Country
  • THAR United States
  • CNEY China
  • Employees
  • THAR N/A
  • CNEY N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • CNEY Major Chemicals
  • Sector
  • THAR Health Care
  • CNEY Industrials
  • Exchange
  • THAR Nasdaq
  • CNEY Nasdaq
  • Market Cap
  • THAR 2.4M
  • CNEY 2.1M
  • IPO Year
  • THAR 2022
  • CNEY 2021
  • Fundamental
  • Price
  • THAR $1.20
  • CNEY $0.13
  • Analyst Decision
  • THAR Strong Buy
  • CNEY
  • Analyst Count
  • THAR 1
  • CNEY 0
  • Target Price
  • THAR $17.00
  • CNEY N/A
  • AVG Volume (30 Days)
  • THAR 97.3K
  • CNEY 9.0M
  • Earning Date
  • THAR 05-08-2025
  • CNEY 01-01-0001
  • Dividend Yield
  • THAR N/A
  • CNEY N/A
  • EPS Growth
  • THAR N/A
  • CNEY N/A
  • EPS
  • THAR N/A
  • CNEY N/A
  • Revenue
  • THAR N/A
  • CNEY $50,957,974.00
  • Revenue This Year
  • THAR N/A
  • CNEY N/A
  • Revenue Next Year
  • THAR N/A
  • CNEY N/A
  • P/E Ratio
  • THAR N/A
  • CNEY N/A
  • Revenue Growth
  • THAR N/A
  • CNEY N/A
  • 52 Week Low
  • THAR $0.95
  • CNEY $0.11
  • 52 Week High
  • THAR $6.45
  • CNEY $1.60
  • Technical
  • Relative Strength Index (RSI)
  • THAR 43.85
  • CNEY 44.70
  • Support Level
  • THAR $1.05
  • CNEY $0.11
  • Resistance Level
  • THAR $1.28
  • CNEY $0.20
  • Average True Range (ATR)
  • THAR 0.11
  • CNEY 0.02
  • MACD
  • THAR 0.02
  • CNEY 0.00
  • Stochastic Oscillator
  • THAR 75.58
  • CNEY 23.09

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

Share on Social Networks: